Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction

Circulation

Volumn 95, Issue 10, 1997, Pages 2368-2373

  Ishikawa, Kinji ^a   Nakai, Shoji ^a   Takenaka, Toshihiko ^a   Kanamasa, Ken ^a   Hama, Junkichi ^a   Ogawa, Iwao ^a   Yamamoto, Tadahiko ^a   Oyaizu, Miki ^a   Kimura, Akio ^a   Yamamoto, Kentaro ^a   Yabushita, Hiroshi ^a   Katori, Ryo ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

angina; death, sudden; myocardial infarction; prevention

Indexed keywords

DILTIAZEM; NIFEDIPINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HEART INFARCTION; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SUDDEN DEATH; TREATMENT OUTCOME;

EID: 17744405878     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.10.2368     Document Type: Article

References (20)

1. The Israeli SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT): a randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J. 1988;9:354-364.
2. Goldbourt U, Behar S, Reicher-Reiss H, Zion M, Mandelzweig L, Kaplinsky E, for the SPRINT Study Group. Early administration of nifedipine in suspected acute myocardial infarction. Arch Intern Med. 1993;153:345-353.
3. Wong S-C, Greenberg H, Hager WD, Dwyer EM Jr. Effects of diltiazem on recurrent myocardial infarction in patients with non-Q wave myocardial infarction. J Am Coll Cardial. 1992;19:1421-1425.
4. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med. 1988;319:385-392.
5. Forrester JS, Diamond GA, Swan HJC. Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cardiol. 1977;39:137-145.
6. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol. 1967;20:457-464.
7. Heger JJ, Weyman AE, Wann LS, Rogers EW, Dillon JC, Feigenbaum H. Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarction. Circulation. 1980;61:1113-1118.
8. Wagner GS, Freye CJ, Palmeri ST, Roark SF, Stack NC, Ideker RE, Harrell FE Jr. Selvester RH. Evaluation of a QRS scoring system for estimating myocardial infarct size, I: specificity and observer agreement. Circulation. 1982;65:342-347.
9. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E, ed. Heart Disease. Philadelphia, Pa: WB Saunders Co; 1992;1:756-789.
10. Miettinen OS. Estimability and estimation in case-referenl studies. Am J Epidemiol. 1976;103:226-235.
11. Yusuf S. Calcium antagonists in coronary artery disease and hypertension: time for reevaluation? Circulation. 1995;92:1079-1082.
12. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J. 1989;299:1187-1192.
13. Gibson RS, Boden WE, Theroux P, Strauss HD, Pratt CM, Gheorghiade M, Capone RJ, Crawford MH, Schlant RC, Kleiger RE, Young PM, Schechtman K, Perryman B, Roberts R, and the Diltiazem Reinfarction Study Group. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction: results of a double-blind, randomized, multicenter trial. N Engl J Med. 1986; 315:423-429.
14. Kloner RA. Nifedipine in ischemic heart disease. Circulation. 1995; 92:1074-1078.
15. Messerli FH, Boden WE, Hansen JF, Schechtman KB. Heart rate lowering calcium antagonists (HRL-CA) in hypertensive post MI patients. J Am Coll Cardiol. 1996;27:178A. Abstract.
16. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NE, Wahl PW, Wagner EH, Furberg CD. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274: 620-625.
17. Messerli FH. 'Cardioprotection': not all calcium antagonists are created equal. Am J Cardiol. 1990;66:855-856.
18. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
19. Opie LH, Messerli FH. Nifedipine and mortality: grave defects in the dossier. Circulation. 1995;92:1068-1073.
20. Boden WE, Scheldewaert R, Walters EG, Whitehead A, Coltart DJ, Santoni J-P, Belgrave G, Starkey IR, for the Incomplete Infarction Trial European Research Collaborators Evaluating Prognosis Post-Thrombolysis (Diltiazem) (INTERCEPT) Research Group. Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Am J Cardiol. 1995;75:1120-1123.